TITLE

Can endoscopic mucosal resection completely remove cancer or dysplasia in Barretts esophagus?

AUTHOR(S)
Wang, Kenneth K; Lutzke, Lori; Buttar, Navtej S; WongKeeSong, Michel; Wandersee, Sarah
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS29
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Can Endoscopic Mucosal Resection Completely Remove Cancer or Dysplasia in Barretts Esophagus?," by Kenneth K. Wang, Lori Lutzke, Navtej S. Buttar, Michel WongKeeSong and Sarah Wandersee is presented.
ACCESSION #
66954493

 

Related Articles

  • Endoscopic appearance and extent of high-grade dysplasia in Barrett's esophagus can predict the presence of cancer at esophagectomy. Buttar, Navtej S; Wang, Kenneth K; Burgart, Lawrence J; M M, Louis; Song, Wong Kee; Lutzke, Lori S; Wandersee, Sarah M; DeMars, Cathrine J; Pacifico, Rodney J // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS28 

    An abstract of the article "Endoscopic Appearance and Extent of High-grade Dysplasia in Barrett's Esophagus Can Predict the Presence of Cancer at Esophagectomy," by Navtej S. Buttar, Kenneth K. Wang, Lawrence J. Burgart, Louis M. M. Wong Kee Song, Lori S. Lutzke and colleagues is presented.

  • Guidelines for the management of Barrett esophagus with high-grade dysplasia? Henteleff, Harry J.; Ellsmere, James C.; Rizk, Nabil // Canadian Journal of Surgery;Oct2011, Vol. 54 Issue 5, p352 

    Objective: To address the role of esophageal resection and other approaches that are becoming increasingly adopted for the management of Barrett esophagus with high-grade dysplasia (HGD). Data sources: MEDLINE, Cochrane Library and the Trip databases were searched for the terms "Barrett's or...

  • Cutting to the chase: circumferential endoscopic mucosal resection for Barrett's neoplasia. Falk, Gary W.; Ginsberg, Gregory G. // Gut;Sep2010, Vol. 59 Issue 9, p1163 

    The article discusses the use of circumferential endoscopic mucosal resection (EMR) in managing Barrett's neoplasia. EMR is considered an important tool in managing patients with both high-grade dysplasia and early carcinoma from a diagnostic, staging and treatment perspective. Compared with...

  • Transoral Endoscopic Inner Layer Esophagectomy: Management of High-Grade Dysplasia and Superficial Cancer with Organ Preservation. Witteman, Bart P. L.; Foxwell, Tyler J.; Monsheimer, Sandy; Gelrud, Andres; Eid, George M.; Nieponice, Alejandro; O'Rourke, Robert W.; Hoppo, Toshitaka; Bouvy, Nicole D.; Badylak, Stephen F.; Jobe, Blair A. // Journal of Gastrointestinal Surgery;Dec2009, Vol. 13 Issue 12, p2104 

    Introduction Limitations of endoscopic therapies for Barrett's esophagus and superficial cancer include a compromised histological assessment, the need for surveillance, subsequent procedures, and stricture formation. Circumferential en bloc resection of the mucosa--submucosa complex followed by...

  • Endotherapy for Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma. Schembre, Drew B. // Journal of Gastrointestinal Surgery;Jul2009, Vol. 13 Issue 7, p1172 

    The article discusses the reason why endoscopic ablative therapies (ET) should serve as a first line treatment for patients with Barrett's esophagus (BE) and high-grade dysplasia (HGD). It was noted that the efficacy of various endoscopic treatments for BE with dysplasia has been shown by...

  • SSAT Controversies Intramucosal Esophageal Cancer and High-Grade Dysplasia: Which Treatment? Peters, Jeffrey H. // Journal of Gastrointestinal Surgery;Jul2009, Vol. 13 Issue 7, p1179 

    The article focuses on the treatment of Barrett's associated high-grade dysplasia (HGD). According to a study by C. Ell et al., endoscopic mucosal resection (EMR) was linked to low morbidity and no mortality and that the neoplastic focus has been removed over a 3-year time span. A study by E. E....

  • Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus. Ayers, Katie; Shi, Chanjuan; Washington, Kay; Yachimski, Patrick // Surgical Endoscopy;Aug2013, Vol. 27 Issue 8, p2836 

    Background: Endoscopic therapy has emerged as an alternative to surgical esophagectomy for the management of Barrett's esophagus (BE)-associated neoplasia. Accurate pretreatment staging is essential to ensure an appropriate choice of therapy and optimal long-term outcomes. This study aimed to...

  • Cost-effective paradigm shift in Barrett's oesophagus?  // PharmacoEconomics & Outcomes News;12/12/2009, Issue 593, p6 

    The article discusses two studies on the treatment of Barrett's oesophagus. The first study concluded that radiofrequency ablation (RFA) is more cost effective than oesophagectomy in treating persistent high-grade dysplasia (HGD) in Barrett's oesophagus. The other study compared the cost...

  • Endoscopie Mucosal Resection (EMR) In Barrett's Esophagus Associated Neoplasia: Recommendations For Pathological Evaluation And Reporting. Muir, Jennifer A.; Marcon, Norman; Aranda-Hernandez, Javier; Cirocco, Maria; Al-Haddad, Sahar; Streutker, Catherine J.; Grin, Andrea // Canadian Journal of Pathology;Winter2015, Vol. 7 Issue 4, p25 

    Endoscopic mucosal resection (EMR) is a minimally-invasive technique increasingly adopted for resection of superficial neoplasia arising in Barrett's esophagus (BE). High-grade dysplasia or adenocarcinoma confined to the mucosa (pTla) should be treated by EMR rather than esophagectomy, as this...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics